Benign and malignant tumors
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adult patients (age 18 or older); 2. Patients with suspected or newly diagnosed or previously treated diseases with benign or malignant conditions (MRI, CT, tumor marker test report or pathology report); 3. Patients who can provide informed consent (signed by the participant, parent or legal representative) 4.Can remain flat and still for more than 15 minutes;
Exclusion criteria
Exclusion criteria: 1. Pregnant patients; 2. Patients with ethanol allergy; 3. Patients with claustrophobia; 4. Patients who are unable to remain flat and still for more than 15 minutes for various reasons; 5. Research participants, parents or legal representatives who are unable or unwilling to provide written informed consent; 6. Patients who, in the opinion of the investigator, are not suitable for participation in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard uptake value max; | — |
Secondary
| Measure | Time frame |
|---|---|
| Standard uptake value mean;Sensitivities;Specificity;Positive predictive value;Negative predictive value;Accuracy; | — |
Countries
China
Contacts
The First Affiliated Hospital of Harbin Medical University